Oral nalbuphine in postpartum pain

Area of Science:

• Pharmacology
• Pain Management
• Obstetrics

Background:

• Postpartum pain, including uterine cramps and episiotomy pain, significantly impacts patient recovery.
• Effective analgesia is crucial for improving the postpartum experience and facilitating early mobilization.

Purpose of the Study:

• To compare the efficacy and safety of oral nalbuphine versus codeine for postpartum pain relief.
• To evaluate the onset and duration of analgesic effects for both medications.

Main Methods:

• A randomized, double-blind, single-dose study involving 121 patients with postpartum pain.
• Comparison of oral nalbuphine (15 mg), codeine (60 mg), and placebo over a 6-hour observation period.

Main Results:

• Both nalbuphine and codeine demonstrated significant pain relief compared to placebo.
• Nalbuphine showed a faster onset of analgesia (0.65 min) than codeine (0.74 min).
• The analgesic effect of nalbuphine diminished more rapidly at the tested dose, with similar adverse event profiles to codeine.

Conclusions:

• Oral nalbuphine and codeine are effective for postpartum pain, with nalbuphine offering a quicker onset.
• Further research may be needed to optimize nalbuphine dosing for sustained postpartum pain management.